131 related articles for article (PubMed ID: 26039026)
21. Clinical profile and outcome of primary hyperparathyroidism accompanied by chronic renal failure.
Mizumoto D; Watanabe Y; Fukuzawa Y; Aoi N; Yamazaki C
Clin Nephrol; 1994 Nov; 42(5):315-21. PubMed ID: 7851033
[TBL] [Abstract][Full Text] [Related]
22. Endocrine Abnormalities in Patients with Chronic Kidney Disease.
Kuczera P; Adamczak M; Wiecek A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):109-18. PubMed ID: 27442377
[TBL] [Abstract][Full Text] [Related]
23. Lipid abnormalities, renal failure, and parathyroid hormone.
Massry SG; Akmal M
Am J Med; 1989 Nov; 87(5N):42N-44N. PubMed ID: 2486546
[TBL] [Abstract][Full Text] [Related]
24. Endocrine dysfunction in chronic renal failure.
Mooradian AD; Morley JE
Arch Intern Med; 1984 Feb; 144(2):351-3. PubMed ID: 6365009
[TBL] [Abstract][Full Text] [Related]
25. Pathogenic mechanisms underlying the variable response to recombinant human growth hormone in children with chronic renal failure.
Schaefer F
Br J Clin Pract Suppl; 1996 Aug; 85():23-5. PubMed ID: 8995024
[TBL] [Abstract][Full Text] [Related]
26. Endocrine sequelae in survivors of childhood cancer.
Oberfield SE; Sklar CA
Adolesc Med; 2002 Feb; 13(1):161-9, viii. PubMed ID: 11841962
[TBL] [Abstract][Full Text] [Related]
27. [Sarcoidosis localized in endocrine glands].
Gostiljac DM; Dordević PB; Maric-zivković J; Canović F
Med Pregl; 2005; 58 Suppl 1():25-9. PubMed ID: 16526262
[TBL] [Abstract][Full Text] [Related]
28. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
Stubbs J; Liu S; Quarles LD
Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of secondary hyperparathyroidism in chronic renal insufficiency.
Portale AA; Morris RC
Miner Electrolyte Metab; 1991; 17(4):211-20. PubMed ID: 1813783
[TBL] [Abstract][Full Text] [Related]
30. Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.
Petryk A; Kanakatti Shankar R; Giri N; Hollenberg AN; Rutter MM; Nathan B; Lodish M; Alter BP; Stratakis CA; Rose SR
J Clin Endocrinol Metab; 2015 Mar; 100(3):803-11. PubMed ID: 25575015
[TBL] [Abstract][Full Text] [Related]
31. Resistance to thyroid hormone.
Refetoff S
Clin Lab Med; 1993 Sep; 13(3):563-81. PubMed ID: 8222575
[TBL] [Abstract][Full Text] [Related]
32. [Renal failure and endocrine insufficiency].
Sugawara A
Nihon Rinsho; 2006 Sep; Suppl 3():571-4. PubMed ID: 17022610
[No Abstract] [Full Text] [Related]
33. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
Korkor AB
N Engl J Med; 1987 Jun; 316(25):1573-7. PubMed ID: 3035373
[TBL] [Abstract][Full Text] [Related]
34. Tertiary hyperparathyroidism after renal transplantation--report of two cases and comparative study of parathyroid function with secondary hyperparathyroidism in chronic renal failure.
Uchida H; Andoh Y; Tomikawa S; Nishimura Y; Nagano T; Ichikawa N; Kikuchi K; Nomura Y; Degawa T; Meigata K
Transplant Proc; 1994 Aug; 26(4):2167-9. PubMed ID: 8066711
[No Abstract] [Full Text] [Related]
35. Parathyroid surgery in renal failure patients.
Dumasius V; Angelos P
Otolaryngol Clin North Am; 2010 Apr; 43(2):433-40, x-xi. PubMed ID: 20510725
[TBL] [Abstract][Full Text] [Related]
36. [Liver and endocrine system. Part II: pituitary-gonadal axis and adrenal gland activity disturbances].
Marek B; Buntner B; Kos-Kudła B; Ostrowska Z; Kajdaniuk D; Zwirska-Korczala K; Adamek B; Karasińska M
Wiad Lek; 1998; 51(7-8):352-9. PubMed ID: 9748891
[TBL] [Abstract][Full Text] [Related]
37. Challenges in the therapy of secondary hyperparathyroidism.
Wood C; González EA; Martin KJ
Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898
[TBL] [Abstract][Full Text] [Related]
38. Endocrine changes in critical illness.
Nylen ES; Muller B
J Intensive Care Med; 2004; 19(2):67-82. PubMed ID: 15070518
[TBL] [Abstract][Full Text] [Related]
39. Derangements of the somatotropic hormone axis in chronic renal failure.
Tönshoff B; Blum WF; Mehls O
Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957
[TBL] [Abstract][Full Text] [Related]
40. [Countermeasure for patients with endocrine disorders due to hemodialysis].
Nihei H
Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1691-5. PubMed ID: 8537726
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
